Open access · CC-BY
via OpenAlex
Randomized controlled trial of once-per-week intermittent fasting for health improvement: the WONDERFUL trial
Ciera L. Bartholomew, Joseph Boone Muhlestein, Heidi Thomas May, Viet Trung Le, Oxana Galenko, Kelly Davis Garrett, Cherie P. Brunker, Ramona O. Hopkins, John F. Carlquist, Kirk U. Knowlton, Jeffrey L. Anderson, Bruce Wayne Bailey, Benjamin Davies Horne
European Heart Journal Open · 2021 · ▲ 35 citations
Abstract
Abstract Aims Low-density lipoprotein cholesterol (LDL-C) predicts heart disease onset and may be reduced by intermittent fasting. Some studies, though, reported that fasting increased LDL-C; however, no study evaluated LDL-C as the primary endpoint. This randomized controlled trial evaluated the effect of low-frequency intermittent fasting on LDL-C and other biomarkers. Methods and results Adults aged 21–70 years were enrolled who were not taking a statin, had modestly elevated LDL-C, had ≥1 metabolic syndrome feature or type 2 diabetes, and were not taking anti-diabetic medication (N = 103). Water-only 24-h fasting was performed twice weekly for 4 weeks and then once weekly for 22 weeks; controls ate ad libitum. The primary outcome was 26-week LDL-C change score. Secondary outcomes (requiring P ≤ 0.01) were 26-week changes in homeostatic model assessment of insulin resistance (HOMA-IR), Metabolic Syndrome Score (MSS), brain-derived neurotrophic factor (BDNF), and MicroCog general cognitive proficiency index (GCPi). Intermittent fasting (n = 50) and control (n = 53) subjects were, respectively, aged 49.3 ± 12.0 and 47.0 ± 9.8 years, predominantly female (66.0% and 67.9%), and overweight (103 ± 24 and 100 ± 21 kg) and had modest LDL-C elevation (124 ± 19 and 128 ± 20 mg/dL). Drop-outs (n = 12 fasting, n = 20 control) provided an evaluable sample of n = 71 (n = 38 fasting, n = 33 control). Intermittent fasting did not change LDL-C (0.2 ± 16.7 mg/dL) vs. control (2.5 ± 19.4 mg/dL; P = 0.59), but it improved HOMA-IR (−0.75 ± 0.79 vs. −0.10 ± 1.06; P = 0.004) and MSS (−0.34 ± 4.72 vs. 0.31 ± 1.98, P = 0.006). BDNF (P = 0.58), GCPi (P = 0.17), and weight (−1.7 ± 4.7 kg vs. 0.2 ± 3.5 kg, P = 0.06) were unchanged. Conclusions A low-frequency intermittent fasting regimen did not reduce LDL-C or improve cognitive function but significantly reduced both HOMA-IR and MSS. Trial registration clinicaltrials.gov, NCT02770313.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/ehjopen/oeab026
- Canonical
- link ↗
- Fetched
- 2026-09-28 MST
Cite this
APA
Bartholomew, C.L., Muhlestein, J.B., May, H.T., Le, V.T., Galenko, O., Garrett, K.D., Brunker, C.P., Hopkins, R.O., Carlquist, J.F., Knowlton, K.U., Anderson, J.L., Bailey, B.W., & Horne, B.D. (2021). Randomized controlled trial of once-per-week intermittent fasting for health improvement: the WONDERFUL trial. <em>European Heart Journal Open</em>. https://doi.org/10.1093/ehjopen/oeab026
Vancouver
Bartholomew CL, Muhlestein JB, May HT, Le VT, Galenko O, Garrett KD, et al. Randomized controlled trial of once-per-week intermittent fasting for health improvement: the WONDERFUL trial. European Heart Journal Open. 2021. doi:10.1093/ehjopen/oeab026.
BibTeX
@article{ciera2021Random,
title = {Randomized controlled trial of once-per-week intermittent fasting for health improvement: the WONDERFUL trial},
author = {Ciera L. Bartholomew and Joseph Boone Muhlestein and Heidi Thomas May and Viet Trung Le and Oxana Galenko and Kelly Davis Garrett and Cherie P. Brunker and Ramona O. Hopkins and John F. Carlquist and Kirk U. Knowlton and Jeffrey L. Anderson and Bruce Wayne Bailey and Benjamin Davies Horne},
journal = {European Heart Journal Open},
year = {2021},
doi = {10.1093/ehjopen/oeab026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Medicine 2023
Citation only
Intermittent fasting plus early time-restricted eating versus calorie restriction and standard care in adults at risk of type 2 diabetes: a randomized controlled trial
Ageing Research Reviews 2016
Preprint · OA
Impact of intermittent fasting on health and disease processes
Insights-Journal of Health and Rehabilitation 2025
Open access · CC-BY
Impact of Intermittent Fasting on Insulin Sensitivity and HbA1c Levels among Overweight Adults with Prediabetes
Journal of Hypertension 2018
Citation only
CARDIOVASCULAR RISK FACTORS AND ARTERIAL STIFFNESS IN MEN AGED 41–43 YEARS
Nutrients 2020
Open access · CC-BY
Does the Energy Restriction Intermittent Fasting Diet Alleviate Metabolic Syndrome Biomarkers? A Randomized Controlled Trial
Nutrients 2024
Open access · CC-BY